Michael Sarcone
Stock Analyst at Jefferies
(n/a)
# 4,441
Out of 5,102 analysts
9
Total ratings
n/a
Success rate
-27.32%
Average return
Main Sectors:
Stocks Rated by Michael Sarcone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Buy | $29 → $36 | $29.98 | +20.08% | 2 | Dec 4, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Hold | $160 → $85 | $137.37 | -38.12% | 1 | Oct 24, 2025 | |
| ALGN Align Technology | Downgrades: Hold | $215 → $140 | $163.87 | -14.57% | 1 | Oct 10, 2025 | |
| EDAP EDAP TMS | Downgrades: Hold | $8 → $2 | $2.35 | -14.89% | 2 | Apr 4, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Hold | $95 | $36.03 | +163.67% | 1 | Nov 14, 2024 | |
| GKOS Glaukos | Upgrades: Buy | $84 → $125 | $109.23 | +14.44% | 1 | May 6, 2024 | |
| PROF Profound Medical | Downgrades: Equal-Weight | $5.5 → $10 | $7.43 | +34.59% | 1 | Mar 21, 2023 |
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $29 → $36
Current: $29.98
Upside: +20.08%
Inspire Medical Systems
Oct 24, 2025
Downgrades: Hold
Price Target: $160 → $85
Current: $137.37
Upside: -38.12%
Align Technology
Oct 10, 2025
Downgrades: Hold
Price Target: $215 → $140
Current: $163.87
Upside: -14.57%
EDAP TMS
Apr 4, 2025
Downgrades: Hold
Price Target: $8 → $2
Current: $2.35
Upside: -14.89%
PROCEPT BioRobotics
Nov 14, 2024
Initiates: Hold
Price Target: $95
Current: $36.03
Upside: +163.67%
Glaukos
May 6, 2024
Upgrades: Buy
Price Target: $84 → $125
Current: $109.23
Upside: +14.44%
Profound Medical
Mar 21, 2023
Downgrades: Equal-Weight
Price Target: $5.5 → $10
Current: $7.43
Upside: +34.59%